Repligen
Healthcare & Life Sci
Company overview
Repligen makes equipment used to manufacture biologic drugs. Its XCell ATF systems handle perfusion and filtration steps early in production. KrosFlo RS uses tangential flow filtration to separate and purify materials during manufacturing. Its PATsmart line of instruments, including ZipChip and MAVEN, monitors the manufacturing process in real time. Repligen is based in Waltham, Massachusetts.
Alexander Rich and Paul Schimmel started Repligen in 1981. It is now a public company, traded on Nasdaq under the ticker RGEN, with about 2,000 employees in the United States, Europe, and Asia, and $738 million in revenue in 2025. Because it sells tools to drugmakers rather than developing its own drugs, its business depends on how much biologic manufacturing its customers are doing, not on any single drug succeeding. Historically, the median salary is ~$155,000. Repligen is an H-1B sponsor.
- Industry
- Healthcare & Life Sci
- Headquarters
- Waltham, United States